Shiseido's portfolio of 31 brands holds 9.3% share of Japan's beauty and personal care market and is ranked No. 3 globally in premium skincare with 7.6% market share. The company is actively implementing its Action Plan 2025-2026, prioritizing structural reforms, financial discipline, and a strategic brand portfolio review to achieve stable and profitable growth.
Cyborg Score Rationale
Aggressive restructuring and global brand investment are driving significant margin expansion and premiumization. However, across the last 12 months, Shiseido generated ¥970.0b of revenue but reported a net loss of ¥40.7b. Drunk Elephant continues to underperform significantly, far below initial expectations, impacting Americas business profitability.
Top Insights
H1 2025 realized ¥13.5 billion in cost reductions on track with plans; two-year cost reduction target raised from ¥45 billion to ¥50 billion.
Clé de Peau Beauté, NARS, and ELIXIR are performing well and driving company-wide growth; fragrance segment showing improvement.
Continued challenges in China and Travel Retail remain headwinds; China market requires further recovery efforts.
Shiseido is set to begin manufacturing in India, joining global players like Estée Lauder and The Body Shop to leverage lower duties and tap into India's market.
Named Competitors
Estée Lauder — Leading global premium beauty and skincare conglomerate
L'Oréal Luxe — Major global cosmetics and luxury beauty player
LVMH Beauty — Luxury conglomerate with diverse beauty portfolio